Package 76282-278-60

{"route": ["ORAL"], "spl_id": "9c981813-533d-40b5-b9ea-5648dd7c7da0", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "upc": ["0376282279107", "0376282280103", "0376282278100", "0376282281100"], "unii": ["0H73WJJ391"], "rxcui": ["151226", "199888", "199889", "199890"], "spl_set_id": ["690baf58-1ec9-463e-99b7-d601362ea56b"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["EXELAN PHARMACEUTICALS INC."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1000 TABLET in 1 BOTTLE (76282-278-10)", "package_ndc": "76282-278-10", "marketing_start_date": "20200907"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (76282-278-60)", "package_ndc": "76282-278-60", "marketing_start_date": "20200907"}], "brand_name": "Topiramate", "product_id": "76282-278_9c981813-533d-40b5-b9ea-5648dd7c7da0", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "76282-278", "generic_name": "Topiramate", "labeler_name": "EXELAN PHARMACEUTICALS INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "25 mg/1"}], "application_number": "ANDA079162", "marketing_category": "ANDA", "marketing_start_date": "20200907", "listing_expiration_date": "20261231"}